Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
基本信息
- 批准号:10584768
- 负责人:
- 金额:$ 73.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-05 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAcute Respiratory Distress SyndromeAdenineAdhesionsAdhesivesAdultAnemiaAttenuatedBloodBlood TransfusionBlood VesselsBlood flowBlood specimenCaliberCardiac OutputCellsChildClinicalConsumptionCouplingCritical IllnessCryopreserved CellDepressed moodEndothelial CellsEndotheliumEnsureErythrocyte TransfusionErythrocytesExposure toFunctional disorderGeneticHemoglobinHomeostasisHumanHypoxemiaHypoxiaImmune responseImpairmentIn VitroIncubatedInfectionInflammationInfluenzaInosineInterventionInvestigationLeukocytesLungMediatingMediatorMetabolicMethodsModelingMorbidity - disease rateMusOralOrganOutcomeOxygenPatientsPeripheralPersonsPhasePhenotypePyruvatePyruvate KinaseRespiration DisordersRespiratory physiologyRiskRisk FactorsRoleSamplingSchemeSepsisSignal TransductionSiteSpecimenTestingTherapeuticTissuesTransfusionTranslationsbiobankcandidate identificationcecal ligation puncturecell injurycell typeclinical investigationclinical translationclinically relevantdesignempowermentexperimental studygenetic approachimprovedin vivoinorganic phosphateinsightlead candidatemortalitymouse modelnovelpharmacologicpreservationprospectiverespiratoryresponseseptictissue oxygenationuptake
项目摘要
ABSTRACT
O2 uptake in the lung and O2 delivery peripherally depend on the efficient matching of blood flow to regional O2
availability in the lung and O2 consumption in tissues. To achieve this matching, red blood cell (RBC) hemoglobin
allostery regulates not only trans-erythrocytic O2 flux but also RBC export of vasoactive mediators that respond
to O2 demand. RBCs export vasoregulatory ATP basally and in response to O2 deficit. This RBC-based vascular
control of the uptake and delivery of O2 may be disrupted by endogenous (e.g., in sepsis) and exogenous (via
storage for transfusion) RBC injuries. Septic persons with moderate anemia are frequently transfused, but
infrequently benefit. Yet conversely any anemia is a negative risk factor. Lung morbidity is frequent after RBC
transfusion, possibly due to impaired RBC ability to export ATP, disrupting O2 uptake via pulmonary RBC-
endothelial adhesion. We show in septic mice (cecal ligation/puncture, CLP) that the RBC’s ability to produce
and export ATP is impaired. We will test the hypothesis that the O2-transport dysfunction in sepsis is
mediated in part by impaired export by RBCs of vasoregulatory ATP, a dysfunction compounded by
transfused RBCs, exacerbating acute lung injury (ALI) and hypoxemia, by achieving these Aims: Aim 1.
Determine the role of RBC ATP export in mortality and ALI in a mouse model of sepsis and transfusion.
Exchange transfusion of CLP RBCs into healthy mice exposed to hypoxia drives mortality. RBC ATP export
takes place via pannexin 1 (Px1). We will determine the role and mechanism of depressed RBC ATP export via
Px1 in the mortality, ALI, and O2 transport responses to sepsis (CLP or severe influenza) and transfusion in mice
using genetic and pharmacological approaches. Aim 2. Determine the influence of augmenting transfusate
RBC ATP content and/or export on organ function and O2 transport in septic mice. RBC ATP export can
be augmented via clinically available approaches: hypoxic RBC storage; transfusate incubation with PIPA
(phosphate, inosine, pyruvate, adenine) solution that preserves stored-RBC ATP and DPG; or using an activator
of RBC pyruvate kinase (PKR), which augments RBC ATP with little effect on DPG or P50. We will test these
approaches to augment or preserve RBC ATP content on ATP export in mice transfused during sepsis. Aim 3.
Determine the influence of human sepsis on RBC vasoregulatory function ex vivo, and the functional
influence of candidate modulators of ATP content and export in septic RBCs. We validated a novel RBC
cryopreservation scheme with superior phenotype fidelity. We built a unique biobank of RBC specimens from
septic children and adults. We prospectively sampled over 150 patients with severe sepsis; most subjects have
ALI. We will determine the influence of translation-ready lead candidates identified in Aim 2 to augment RBC
ATP export on key RBC respiratory functions: vasoactivity, anti-adhesivity, and O2 transport. We will model the
effects of transfusate intervention in admixed septic and stored RBCs. Our novel focus on disrupted signaling by
RBCs will produce novel, practical, and relevant insight into respiratory dysfunction in sepsis and transfusion.
摘要
肺中的氧气摄取和外周的氧气输送依赖于血流与局部氧气的有效匹配
肺中的利用度和组织中的氧气消耗。为了实现这种匹配,红细胞(RBC)血红蛋白
变构不仅调节跨红细胞的O2流量,而且调节RBC输出的血管活性介质
对氧气的需求。红细胞基础上输出血管调节性三磷酸腺苷,并对氧气缺乏作出反应。这种以红细胞为基础的血管
内源性(例如,在脓毒症中)和外源性(通过
储存输血)RBC损伤。有中度贫血的败血症患者经常输血,但
很少受益。然而,相反,任何贫血都是一个负面的风险因素。RBC后肺部并发症多见
输血,可能是由于红细胞输出ATP的能力受损,扰乱了通过肺红细胞摄取氧气的能力-
内皮细胞粘连。我们在脓毒症小鼠(盲肠结扎/穿孔,CLP)中表明,红细胞产生
以及出口ATP受到损害。我们将验证脓毒症患者O2-转运功能障碍的假设
部分原因是红细胞对血管调节三磷酸腺苷的输出受损,这种功能障碍由
通过输注红细胞,加重急性肺损伤(ALI)和低氧血症,达到以下目的:1.
在脓毒症和输血的小鼠模型中,确定RBC-ATP输出在死亡率和ALI中的作用。
在暴露在低氧环境下的健康小鼠中交换输注CLP红细胞可增加死亡率。RBC ATP导出
通过pAnnexin 1(PX1)发生。我们将通过以下途径确定抑制红细胞ATP出口的作用和机制
PX1在脓毒症(CLP或严重流感)和输血引起的小鼠死亡率、ALI和O2转运反应中的作用
使用遗传和药理学方法。目的2.确定增加输血量的影响
败血症小鼠红细胞ATP含量和/或输出对器官功能和O2转运的影响。RBC ATP出口可以
通过临床可用的方法:低氧保存红细胞;与PIPA输注孵育
(磷酸盐、肌苷、丙酮酸、腺嘌呤)保存储存的红细胞ATP和DPG的溶液;或使用激活剂
RBC丙酮酸激酶(PKR)升高RBC ATP,但对DPG或P50影响不大。我们将测试这些
在脓毒症期间输血的小鼠体内增加或保存红细胞ATP含量的方法。目标3.
体外测定人脓毒症对RBC血管调节功能的影响
脓毒症红细胞中ATP含量和输出的候选调节剂的影响。我们验证了一种新的红细胞
表型保真度高的冷冻保存方案。我们建立了一个独特的红血球样本生物库
败血症儿童和成人。我们前瞻性地抽样了150多名严重脓毒症患者;大多数受试者都有
阿里。我们将确定目标2中确定的可用于翻译的主要候选人对增强RBC的影响
ATP输出对关键的红细胞呼吸功能:血管活性、抗粘附性和氧气运输。我们将为
输注干预对混合败血症和储存红细胞的影响。我们的新重点是通过以下方式中断信号
红细胞计数将对败血症和输血中的呼吸功能障碍产生新的、实用的和相关的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLAN DOCTOR其他文献
ALLAN DOCTOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLAN DOCTOR', 18)}}的其他基金
ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute
ErythroMer:纳米级生物合成红细胞替代品
- 批准号:
9347784 - 财政年份:2017
- 资助金额:
$ 73.14万 - 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
- 批准号:
9229050 - 财政年份:2015
- 资助金额:
$ 73.14万 - 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
- 批准号:
8803196 - 财政年份:2015
- 资助金额:
$ 73.14万 - 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
- 批准号:
9069918 - 财政年份:2015
- 资助金额:
$ 73.14万 - 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
- 批准号:
9273245 - 财政年份:2015
- 资助金额:
$ 73.14万 - 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
- 批准号:
6710786 - 财政年份:2004
- 资助金额:
$ 73.14万 - 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
- 批准号:
7350865 - 财政年份:2004
- 资助金额:
$ 73.14万 - 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
- 批准号:
6839438 - 财政年份:2004
- 资助金额:
$ 73.14万 - 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
- 批准号:
7250307 - 财政年份:2004
- 资助金额:
$ 73.14万 - 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
- 批准号:
7163407 - 财政年份:2004
- 资助金额:
$ 73.14万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 73.14万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 73.14万 - 项目类别: